Allergan Q4 Adj. EPS $5.22 Beats $4.57 Estimate, Sales $4.351B Beat $4.09B Estimate

Allergan (NYSE:AGN) reported quarterly earnings of $5.22 per share which beat the analyst consensus estimate of $4.57 by 14.22 percent. This is a 21.68 percent increase over earnings of $4.29 per share from the same

Benzinga · 02/10/2020 12:03

Allergan (NYSE:AGN) reported quarterly earnings of $5.22 per share which beat the analyst consensus estimate of $4.57 by 14.22 percent. This is a 21.68 percent increase over earnings of $4.29 per share from the same period last year. The company reported quarterly sales of $4.351 billion which beat the analyst consensus estimate of $4.09 billion by 6.38 percent. This is a 6.64 percent increase over sales of $4.08 billion the same period last year.